alexa Geraniol - A Component Of Rosa Alba L. Essential Oil, Possess Anti-genotoxic Activity Against MNNGinduced Chromosome Aberrations In Higher Plants And Cultured Human Lymphocytes
ISSN: 2329-6836

Natural Products Chemistry & Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference and Exhibition on Marine Drugs and Natural Products
June 15-17, 2017 London, UK

Svetla Gateva, Gabriele Jovtchev, Alexander Stankov and Milka Mileva
IBER, Bulgaria
Stephan Angeloff Institute of Microbiology, Bulgaria
Posters & Accepted Abstracts: Nat Prod Chem Res
DOI: 10.4172/2329-6836-C1-014
Abstract
Rosa alba L. is a rich source of natural antioxidants and holds promise to be successfully used in perfumery, cosmetics and pharmacy. The natural monoterpene geraniol comprises 18.28% of the Rosa alba L. essential oil. The compound was tested with respect to its potential to protect cells against DNA alkylating agent N-methyl-N’-nitro-N-nitrosoguanidine (MNNG), as well as to its cytotoxic and genotoxic activities in two types of test-systems: Hordeum vulgare and human lymphocytes in vitro. Such studies with physiologically different types of test-systems could provide more informative and representative assessment about the cytotoxic/genotoxic effect and protective potential of the compounds isolated from white rose essential oil against genotoxins. The objective of the study was to evaluate cytotoxic/clastogenic effect and anti-cytotoxic/anti-clastogenic potential of geraniol (ethanolic extract) evaluated by chromosome aberration test in barley (reconstructed karyotype MK14/2034) and cultured human lymphocytes. Two types of experimental schemes were applied: single treatment with compounds, conditional treatment with geraniol prior to challenge with MNNG with or without 4 h inter-treatment time. The presented data reveals no cytotoxic effect in all geraniol individual treatment variants compared with untreated control. Geraniol shows anti-clastogenic potential against MNNG induced chromosomal aberrations in both test-systems. It is effective in concentration range of 25, 50 and 100 μg/ml and shows a substantial impact after conditional treatment prior to MNNG (50 μg/ml) without or with 4h intertreatment time. The frequency of chromosome aberrations was decreased in dependence of the concentration applied and the treatment variant. 34-60% less injury was detected in lymphocytes and 53-75% in barley compared with the challenging treatment with MNNG alone. These investigations, concerning the anti-cytotoxic and anti-genotoxic potential of geraniol could be useful in health research on the pharmacological capacity and activity of the present and other natural plant compounds.
Biography

Svetla Gateva has experience in the field of genotoxicity screening and risk assessment of various environmental contaminants using human lymphocytes as a test-system. She has experience with classical cytogenetic techniques (chromosome aberrations, micronuclei) and molecular methods (comet analysis and gel electrophoresis in a constant electric field/CFGE).

Email: spetkova2002@yahoo.co.uk

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

agriaquaculture@omicsonline.com

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

biochemjournals@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

chemistryjournals@omicsonline.com

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

clinicaljournals@omicsonline.com

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engineeringjournals@omicsonline.com

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

nutritionjournals@omicsonline.com

1-702-714-7001Extn: 9042

General Science

Andrea Jason

generalscience@omicsonline.com

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

geneticsmolbio@omicsonline.com

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immunomicrobiol@omicsonline.com

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

nursinghealthcare@omicsonline.com

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

medicaljournals@omicsonline.com

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuropsychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

pharmajournals@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords